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ABSTRACT

Sattiraju, Sandhya Ramani M.S. Department of Biochemistry and Molecular biology,
Wright State University, 2020. Apoptosis and necrosis drive muscle fiber loss in lipin1
deficient skeletal muscle.
Mutations in lipin1 are suggested to be a common cause of massive rhabdomyolysis episodes
in children, however, the molecular mechanism involved in the regulation of myofiber death
by lipin1 is not known. In this study, we utilized the skeletal muscle from cell-type-specific
lipin1 knockout (Lipin1Myf5cKO) mice to define cell death pathways involved in lipin1 deficient
muscles. We observed a significant increase in centrally nucleated fibers and embryonic
myosin heavy chain (EMyHC)-positive regenerating fibers in Lipin1Myf5cKO mice compared to
wild-type (WT) mice, indicating an increased cycle of degeneration and regeneration in lipin1
deficient muscles. Lipin1 deficient muscles had significantly elevated pro-apoptotic factors
(Bax, Bak, and cleaved caspase 9) and necroptotic proteins such as RIPK1, RIPK3, and MLKL
compared with WT mice. Moreover, loss of membrane integrity is considered as a hallmark of
cell death and we found that Lipin1Myf5cKO mice had significantly higher membrane disruptions
as evidenced by increased IgG staining and elevated uptake of Evans Blue Dye (EBD) in
muscle fibers. EBD-positive fibers were strongly colocalized with apoptotic or necrotic
myofibers, suggesting an association between compromised plasma membrane integrity and
cell death pathways. We further show that the absence of lipin1 leads to a significant decrease
in the absolute and specific muscle force (normalized to muscle mass). Our work indicates that
apoptosis and necroptosis are associated with a loss of membrane integrity in muscle lacking
lipin1 and myofiber death may induce an expected decrease in contractile force and a defect in
muscle function.
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I.

i.

INTRODUCTION

Skeletal myopathy

Skeletal myopathies are a group of diseases that are characterized by progressive muscle
atrophy and weakness (K. Josiak et al., 2014). The basic characteristics of myopathies are
muscle weakening, muscle pain, and, muscular dysfunction. Myopathy patients are usually
recognized with continuous inflammation and weakness of the muscle. Myopathies are
grouped as hereditary and acquired disorders (Furst D.E. et al., 2012). The hereditary type of
myopathies includes muscular dystrophies, congenital myopathies, metabolic myopathies,
and mitochondrial myopathies. Muscular dystrophies are caused by an abnormal gene
(germline mutations) which interferes with the production of muscle proteins that are essential
for the muscle development. Most form of this condition is observed in early childhood.
Damaged muscles become progressively weaker. (González-Jamett et al., 2018). Dystrophic
patterns i.e. degenerative patterns with necrosis and extensive fibrosis in the muscles are
observed and also the central nervous system is involved in muscular dystrophic patients
(Koutsoulidou, A et al., 2020). In congenital myopathies, where the patients are born with the
underdeveloped skeletal motor system due to which they lack muscle tone and has enhanced
muscle weakness. Other myopathies are mitochondrial myopathies which are caused by the
defects in the mitochondrial functioning affecting the muscular function (Pfeffer, G. et al.,
2011). On the other hand the inflammatory, endocrine, and toxic myopathies are included in
the acquired group of myopathies.
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During muscle injury conditions ATP starts depleting. As a result, there’s an excessive influx
of intracellular sodium and calcium ions. The prolonged presence of calcium ions signals the
muscles for sustained myofibrillar contractions which depletes the ATP further (Al-Ismaili Z
et al., 2011). The increased levels of calcium ion activate the proteases and phospholipases
which promotes lysis of cellular membrane and further damage to the ion channels (HuertaAlardín AL et al., 2011). All these events lead to alternations in myocyte milieu causing
inflammation, self-sustained myolytic cascade which causes necrosis and release all the blood
components into the muscle environment. These alterations initiate the rhabdomyolysis
cascade in patients (Vanholder R et al., 2000).

ii.

Rhabdomyolysis

Rhabdomyolysis is a rare condition in which skeletal muscle breaks down, releasing muscle
enzymes and electrolytes from inside the muscle cells. Patients who suffer from overwhelming
myopathy associated rhabdomyolysis lead to muscle atrophy (muscle loss) and myalgia
(muscle pain) (Nance J.R. et al., 2015). The clinical diagnosis of myopathy is made when there
are muscle pain and muscle weakness along with elevated levels of CK (Creatinine Kinase).
Hence, rhabdomyolysis is known as a severe form of myopathy with muscle breakdown
leading to myoglobinuria and finally acute renal failure (Omar MA et al., 2001).
Rhabdomyolysis is a state of injury that can lead to the rapid dissolution of damaged or injured
skeletal muscle fibers. Injury of skeletal muscle disrupts the integrity leading to the release of
cellular components including myoglobin, creatine kinase into the bloodstream, and
extracellular space of the muscle (Huerta-Alardín AL et al., 2011). All these events result in
etiology such as muscle pain, muscle weakness, and muscle swelling.
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Biochemically, an important symptom of this disease is the darkening of the urine
(pigmenturia), known as myoglobinuria. The other evidence is plasma myoglobin increases
rapidly and immediately eliminated from the body through renal excretion. This is observed
often during post-muscle injury conditions. (P Koskelo et al., 1967). However, all these various
initial laboratory evaluations do not necessarily explain the acquired cause of rhabdomyolysis
(Nance J.R. et al., 2016). Thus, the researchers anticipate that most of the rhabdomyolysis cases
have inherited susceptibility.
Rhabdomyolysis can be caused by a wide range of diseases, which could be
classified as sporadic or hereditary/recurrent. According to a recent statistical study depicted
that around 26,000 cases were reported annually only in the USA by the National Hospital
Discharge Survey. (Melli G et al., 2005). Most of these rhabdomyolysis cases in the adult
population are acquired type. This disease is also observed in early childhood which is caused
by somatic mutations (Alaygut D. et al., 2017). Clinical etiology in a recurrent type of
rhabdomyolysis is different from the acquired type of rhabdomyolysis. In childhood, viral
myositis, trauma, collective tissue disorders are responsible for rhabdomyolysis (Torres P.A.
et al., 2015). In this disease initiation of the viral infection may leads to a serious condition of
muscle degeneration, accounting for one-third of pediatric cases in the USA (Brinley A et al.,
2018). Muscle degeneration is one of the clinical manifestations of rhabdomyolysis.

iii.

Apoptosis

We discussed in the previous sections about muscle loss and degeneration leading to severe
cases of Rhabdomyolysis. These events initiate due to the myoblast death in muscle tissues.
(George G.D. et al., 2006). This muscular degeneration can be caused by various cellular
processes in which apoptosis is one of the major contributors. Apoptosis is an important process
in multicellular organisms to self-destroy when no longer needed or during damage conditions.
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It is popularly defined as the process of programmed cell death (Alberts B. et al., 2013). During
the initial studies on cell death, regulated and advanced stages were first reported in the larval
muscles. Eventually, myobiology researchers concluded that mammalian skeletal muscles also
undergo an apoptotic way of cell death. This study leads to breakthroughs in various musclerelated diseases (Sandri M. et al.,1999). The cellular and molecular aspects of myoblasts and
myofibers apoptosis and their roles in disease are the present areas of interest in the field of
myobiology. This programmed cell death can be triggered in two ways, via intrinsic pathway,
which is an endogenous system such as Bax/Bcl2 or via extrinsic system Fas and Fas L
involving transmembrane receptors of death receptor family.

iii.1 Intrinsic Apoptosis

The intrinsic pathway is usually observed in all muscle degeneration related diseases. For
instance, in DMD disease, in response to an injured environment, impaired regeneration is
observed in muscle cells. The aim to study the degeneration and regeneration in muscle cells
can be measured by intrinsic pathway markers (Abdel-Salam E. et al., 2009). In this pathway,
cells must undergo metabolic stress in order to activate Bcl2 family-related proteins and initiate
caspase cascade (Elmore S. et al., 2007). The mitochondria are closely involved in the process
of apoptosis as it has two main characteristics. Firstly, the intermembrane space of
mitochondria contains distinct pro-apoptotic proteins which can activate the apoptosis leading
to cell death upon getting released into the cytosol. Secondly, the mitochondria have
fundamental producers of reactive oxygen species which can sometimes have a direct or
indirect effect on apoptosis (Adhihetty P.J. et al., 2003).
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The composition of mitochondria consists of the outer and inner membrane which separated
by intermembrane space. When considered the intrinsic apoptosis in skeletal muscle, up to date
limited research was focused on determining the physiological and pathophysiological
condition which leads to apoptosis. When muscle tissues and differentiated muscle cells are
subjected to experimentation, the intrinsic apoptosis is initiated by a diverse array of nonreceptor mediated stimuli that produce intercellular signals on cells activating the
mitochondrial events (Elmore S. et al., 2007). In response to the stimulus, alterations in the
ratios of pro-apoptotic proteins (Bax and Bak) and anti-apoptotic proteins (Bcl2 and Bclxl)
leads to the activation of initiation caspases i.e. caspase 9 (Kale J et al., 2018). The release of
cytochrome c from the mitochondria allows the initiation of a caspase cascade. Therefore, once
the initiation caspase is activated, all the other caspases such as caspase 3 are cleaved and
activated leading to DNA fragmentation. The evidence of apoptosis cell death can be found in
numerous skeletal muscle myopathies such as muscular dystrophy and also congenital
myopathies. In these muscle degenerative diseases, excessive muscle cell death leads to muscle
loss and atrophy (Tews D.S. et al., 1996).

iii.2 Extrinsic apoptosis

Skeletal muscle can also undergo extrinsic stimulus-related apoptosis. This is mainly observed
in muscle mass losses during muscular degeneration. The extrinsic pathway develops due to
the ligand-mediated stimulation of death receptors located at the plasma membrane of the cell.
Extracellular receptors such as cytokine TNF-𝛼 and Fas-Ligand (Fas-L) are usually found on
the cytotoxic T-lymphocytes and various other immune cells. These ligand binding plays a
vital role in the activation of a definite set of proteases which leads to the entire process of
Apoptosis (Kumar S. et al.,1999). These commonly occur during the early phase of Apoptosis.
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The caspases can behave in a cascade-like fashion which occurs in the mid-phase of extrinsic
apoptosis (Nicholson D.W. et al., 1999). The cell response to the binding of Fas-L binds to the
Fas receptors. This binding sequesters the procaspase8 to the cellular membrane by FADD (Fas
Associated Death Domains), an adaptor protein that is closely bound to the Fas receptors
(Baker S.J. et al., 1998). Accumulation of caspase-8 near the DISC (Death-inducing signaling
complex) at the plasma membrane leads to the activation of caspase-8. Activated caspase-8 can
directly cleave and simultaneously activate caspase-3 exerting its apoptotic effects on the
structures of the cell membrane. These caspase activations are responsible for the cytosolic
biochemical breakdown and nuclear targets leading to distinct morphological features of
apoptosis (Hood D.A et al., 2003).

Figure 1: Apoptotic cell death pathway in skeletal muscle. (Westphal D. et al., 2011)
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iv.

Necrosis

Necrosis is the highly effective and rapid form of cell death in which essentially every part of
the cell starts disintegrating. It is especially characterized by deregulation in the cell ion
homeostasis which leads to cell swelling, a characterized dilation is observed in mitochondria
along with endoplasmic reticulum (Mattson M.P. et al., 2012). Many skeletal muscle diseases
such as Muscular dystrophy, myopathy, and others are estimated to occur due to necrosis way
of cell death (Lopes Ferreira M. et al., 2001). Degeneration of myofibers is multifactorial but
the myofibers are susceptible to the mechanical stress, cytotoxic factors induced and more
importantly these various factors cause an inflammatory process which leads to excessive
muscle loss (Rosenberg A.S. et al., 2015). Historically, necrosis is known to be an unregulated
means of cell death, but recent studies have shown that necrosis can genetically be controlled;
which is termed as ‘Necroptosis’ (Degterev A. et al., 2005). This Necroptosis is a caspaseindependent cell death pathway, but it insignificantly overlaps with the extrinsic apoptotic
pathway (Chen Q. et al., 2018). Few proteins are common in both pathways such as Tumor
necrosis factor- 𝛼 (TNF𝛼) which is an inflammatory cytokine, but it also acts as a strong pronecrosis factor in myofibers. TNF𝛼 involves two members of the receptor-interacting protein
(RIP) family of kinases which form complex to ultimately stimulate the inflammation proteins
in the cell. Hence, necroptosis/ necrosis muscle fibers show huge characteristic inflammation
(Morgan J. E. et al., 2018). The ubiquitinated links are attached to prevent caspase 8 or RIPK3
interaction with the RIPK1 to induce death signals and consequently lead the cell survival, all
this is termed as Complex I. Fas-associated death domain (FADD) and pro-caspase 8 interact
which forms a Death inducing signaling cascade (DISC).
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This complex when dissociated from the plasma membrane forms a Complex II (Linkermann
A. et al., 2013). The activity of Caspase-8 increases with the proximity to complex II. Hence,
the important role of active caspase 8 is to prevent necroptotic activity. This can be effectively
achieved when RIPK1and RIPK3 is cleaved to form a necroptosome. This necroptosome
consists of RIPK1 and RIPK3 along with a Mixed linage kinase-like domain (MLKL)
(Jevnikar A.M. et al., 2013). The recruitment of MLKL is finally leading to the disruption of
the membrane and resulting in irreparable damage to the muscle cells (Reigger J. et al., 2019).

Figure 2:Necroptotic (Necro-apoptotic) pathways observed in skeletal muscle
(Escobar M.L. et al., 2015)

The apoptosis is known to be the popular form of programmed cell death (PCD) which is
regulated by distinct Caspase cascade. When this programmed cell death signaling is
dysregulated the cell death pathway shift to Necroptosis which can major defects in the
developmental stages. This necroptosis pathway regulated by a few specific Receptor

8

interacting protein kinases 1 and RIPK3. These kinases act as important signaling interactions
as they promote the recruitment of MLKL. Tumor necrosis factor (TNF-1)- ligation induces
signaling via the NF-𝜅B pathway which involves the polyubiquitination of RIPK1. RIPK1
loses its default pro-survival function to promote cell death function (Linkermann A. et al.,
2014). The pathway in which cells induce cell death RIPK1 and RIPK3 interact with each other
via RIP homotypic interaction motifs (RHIMs) which is present in both kinases.
These interactions between RIPs form ‘necrosome’ which an oligomeric cytosolic complex in
which reciprocal phosphorylation of RIPK1 and RIPK3 leads to recruitment and activation of
MLKL (Orozco S. L. et al., 2018). The activated MLKL is translocated to and gets disrupted
in the plasma membrane. Loss of membrane integrity during necroptosis results in the release
of cellular contents leading to inflammatory responses in the muscles (Zhang X. et al., 2019).

v.

Lipin1

In the human body, triacylglycerols (TAG) are the long-term storage sites in adipose tissue,
and they provide a huge source of fatty acids. Fatty acids undergo oxidation reactions to provide
energy to the skeletal muscles (Greenberg A.S. et al., 2011). Lipin1 is an intracellular protein
that controls metabolism by acting at different regulatory levels (Harris T.E. et al., 2011).
Lipin1 is an Mg2+ - dependent phosphatidic acid phosphatase enzyme (PAP1). This is a very
essential enzyme used for lipid biosynthesis and adipocyte differentiation. This lipin protein
family consists of three members, lipin1, lipin2, and lipin3.
Out of all these lipin proteins, lipin1 is the most prominent protein as it is expressed in both
adipose tissue and skeletal muscle. (Carman G.M. et al., 2009) they discovered that lipin1 has
two crucial molecular functions. Firstly, lipin1 acts as a phosphatide acid phosphatase activity
(PAP1) enzyme which catalyzes the phosphatide (PA) to diacylglycerol (DAG) particularly
during triglycerides (TGs), phosphocholine (PC) and phosphatidylethanolamine biosynthesis
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(Carman G.M. et al., 2009). Secondly, lipin1 is expressed in various tissues but the most
prominent expression is observed in adipose tissue, skeletal muscle and testis (Reue K. et al.,
2009). Lipin1 nuclear function may be related to transcription coactivation (Finck et al., 2006)
which helps in activating hepatic fatty acid oxidation genes during fasting conditions. Lipin1
precisely interacts with Peroxisome Proliferator Activator Receptor 𝛼 (PPAR𝛼) and PPAR𝛾
coactivator 1𝛼 (PGC1𝛼). These combined forms a complex and modulates the fatty acid
oxidation expression.

Figure 3:Representation of classical roles in lipin1(Y. Chen et al, 2015)

Figure 3 depicts the structural representation of the lipin1 protein. All the lipin1 protein
family has two evolutionarily conserved regions. These regions are N-LIP (N-terminal) and
C-LIP (C-terminal) of the lipin gene. Both terminals had different motifs that express very
specific functions of the lipin gene. N-LIP has NLS (Nuclear Localization Signal) the domain
which is arginine and lysine-rich region. This motif helps lipin to translocate to the nucleus
and this subcellular localization can be influenced by protein phosphorylation.
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On the other hand, C-LIP has two protein functional motifs; one is a haloacid dehalogenase
(HAD)-like phosphatase motif DXDXT, this helps in enzymatic activity of the lipin1 i.e.
phosphatidate phosphatase activity. Another motif is LXXIL which is a nuclear receptor
interaction motif regulating the transcription coactivator activity of the nuclear lipin. (Y.
Chen et al., 2015).

The lipin1 family was first identified in a spontaneous mutant mouse strain, which was later
named as fatty liver dystrophy(fld). These mutated mice showed a dysregulated fatty acid
synthesis (Csaki et al., 2013; Peterfy et al., 2001; Wang H. et al., 2017). Through positional
cloning (Peterfy et al., 2001) lipin1 was identified in mice. In a subset of individuals
mutations in these mice characterize to exhibit lipodystrophy, hypertriglyceridemia, neonatal
fatty liver, insulin resistance, and peripheral neuropathy (Y. Chen et al., 2015). Humans also
exhibit similar phenotypes for the same lipin1 mutations as observed in mice and they exhibit
smaller & atrophied muscle (Michot et al., 2012; Jiang et al., 2015). According to a recent
study, human patients with lipin1 mutations tend to show severe cases of rhabdomyolysis
(Michot C. et al., 2012). Along with rhabdomyolysis they also observed excessive
accumulation of lipid droplets in the skeletal muscles (Michot C. et al., 2012; Chen Y. et al.,
2015). However, the current understanding of lipin1 doesn’t explain the phenotypes seen in
these rhabdomyolysis patients. Our lab aims to research on different roles of lipin1 in various
muscle degenerative diseases.
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vi.

Hypothesis and aims

Recent studies have explained that deficiency of lipin1 leads to severe episodes of
rhabdomyolysis (Michot C. et al., 2012). Our laboratory has already found that lipin1
deficiency leads to increased centrally nucleation in skeletal muscle (Jama A. et al., 2018).
Therefore, we hypothesize that lipin1 deficiency promotes muscle degeneration through
apoptosis and necrosis. With this ideology, we came up with three aims: 1) whether lipin1
deficiency leads to apoptosis and necroptosis in skeletal muscles. This degeneration is
explained by aim 2) whether deficiency affects membrane integrity and muscle function. As
mentioned in earlier chapters, muscle injury is the initiation of degradation in myofibers
leading to myofiber death. In which necroptosis and apoptosis contribute to major degeneration
of muscle fibers. 3) To determine whether myofiber death is associated with plasma membrane
disruption.
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II.

i.

MATERIALS AND METHODS

Animal
Generation of Lipin1 Myf5cKO knockout mice
To generate Lipin1

Myf5cKO

, we crossed Lipin1flox/flox (Nadra et al., 2008) with myf-Cre

mice. These myf-Cre mice were acquired from Jackson’s Laboratory (Stock no: 007893).
This study was performed using Lipin1 wildtype mice and skeletal muscle-specific lipin1
deficient knockout mice. To check the genotype information of these mice, mice tails were
collected from respective pups. Experiments were performed on 2-4‐months‐old mice.
These mice had free access to drinking water and regular chow. All animal experiments
were performed under the relevant guidelines and regulations approved by the Animal Care
and Use Committee of Wright State University.

ii.

Tissue collection and cutting
Optimal Cutting Temperature (OCT) was used to immerse the entire muscle and later
they were dipped in -160 °C isopentane for 20 seconds. To maintain the temperature of the
fixed tissue, they are put on dry ice for a few seconds before storing them in the -80 °C
freezer. These fixed tissues are used for various staining when they are cut at a thickness
of 7μm using the Cryostat Thermo Scientific Microm HM550. This machine is usually
maintained at -20°C.
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iii.

Western blotting

This was used to analyze the different biomarkers of apoptosis and necrosis. Muscle
tissues were isolated and snap-frozen in liquid nitrogen for subsequent homogenization
or lysed

in

RIPA

buffer (10 mM Tris‐HCL

pH

7.4,

30 mM NaCl,

1 mM EDTA, 1% Nonidet P‐40) supplemented with proteinase inhibitors (SIGMA
complete

TM

Protease Inhibitor Cocktail 04691166001) and phosphatase inhibitors

(SIGMA P2850 -Phosphate Cocktail1) before the use. We used 1ml 1X RIPA buffer +
0.2% Protease + 0.2% Phosphatase. We used tissue samples for the experiments. Frozen
tissue samples were thawed at room temperature by letting them on ice for about 10mins.
About 20- 50 mg of tissue was added to 450μl of homogenizing mixture for each sample.
Samples were subjected to centrifugation at 12000rpm at 4°C for 10mins. Protein
concentration was measured using bicinchoninic acid (BCA) assay. Bovine serum albumin
(BSA) of concentration 2mg/ml was used as standard (0, 2μl, 4μl, 6μl, 10μl, 12μl were
loaded in a 96well plate). 3ul-5ul of the sample was added to the plate. Each standard and
sample was duplicated for precision. Assay plates were incubated in a 37°C incubator for
20-30mins. Later these plates were analyzed for protein absorbance at a wavelength of 567
using Synergy H1 microplate reader. The BCA assay standard curve provided the
concentration values for the samples to-be added for western blotting.
Gels were prepared using (30% acrylamide solution; 37:5:1 BioRad Cat: 1610158)
separated by 7.5–15% SDS‐PAGE to separate the protein based on their polypeptide chain
length. The desired amount of protein (20 μg - 60 μg) was measured before running the
samples and adjusted the volumes using RIPA buffer and 4X loading dye. Muscle lysates
were determined for concentration in each sample and equal amounts of proteins were used,
boiled at 95°C for 5 min in 1 × SDS sample buffer.
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Thenceforth, the protein ladder (Fisher CatNo:26616) (Bio-Rad; Cat No:161-0373) and
protein samples were loaded on the gel-filled with 1X running buffer. The power was set
to a voltage of 100V and eventually changed to 120V with 0.3 A current for the proteins to
enter into the stacking gel. Later, proteins were transferred to polyvinylidene
difluoride membranes (Millipore, Billerica, MA, USA) using a Mini Trans‐Blot Cell
System (Bio‐Rad, Hercules, CA, USA) which were soaked in methanol for 1-3 mins and
then transferred into transfer buffer. Filter papers and sponges were all soaked in the 1X
transfer buffer. Once gels are finished running, they were removed from the plates and
placed on the filter paper and then PVDF membrane, finally closed them with sponges
around them. To transfer the proteins, the membranes were stacked into the gel holder
cassette of the transfer system. These cassettes are transferred into the transferring box
equipment, set at voltage 150V and 0.3 A current for a span of 2 hrs submerged in a box of
ice. The membranes are separated from the cassettes and subjected to blocking to avoid the
extra unspecific binding. A blocking buffer is prepared using a 1% casein buffer and 1X
TBS solution in a 1:9 ratio. These blots are cut according to the desired biomarker size and
incubated for about 1hr. Later these blots are incubated with the primary antibodies
overnight at 4°C. Primary antibodies used include lipin1 (#14906; Cell Signaling
Technology, Beverly, MA, USA), Bax (#2772), Bak (#12105), Bcl-2 (#3498), Bcl-xl
(#2764), cleavedcaspase9(ccp9, #9508), cleavedcaspase3(ccp3, #9664), RIPK3 (#95702),
RIPK1 (#3493T), and MLKL (#37705S). These different primary antibodies are diluted
using antibody solution (10% casein and 0.1% Tween 20). After overnight incubation, these
blots are washed (3X) with TBST solution (1X TBS and 0.1% Tween 20, Fisher
CatNo:175476). Then the same blots are probed with secondary antibodies for 1h at 25°C.
After the incubation, blots are washed again with TBST solution.

15

Protein bands were detected by using Chemiluminescence kit from PierceTM ECL western
blotting substrate (catalog #32106). The instrument used to visualize in Amersham Imager
600 (GE Healthcare Life Sciences, Little Chalfont, UK). Goat anti‐mouse IgG‐HRP
(#w402B; Promega, Madison, WI, USA) and goat anti‐rabbit IgG‐HRP (#w401B;
Promega) secondary antibodies were used for detection. GAPDH (Ab181602; Abcam)
antibody was used as a loading control. Western blots were quantified by densitometry
using NIH Image J software and all values were normalized to loading control.

iv.

Histological and Immunohistochemical analysis
Lipin1Myf5cKO and WT mice for each group were euthanized for histological or
immunohistochemical analysis. Immediately following sacrifice, the gastrocnemius
muscles were dissected and frozen in 2-methyl butane chilled to a slurry on liquid nitrogen.
Sections of frozen tissue were prepared at 7-15 μm using a cryostat and stored these
cryosection biopsies on microscope slides (Thermofisher Cat No: 22-230-900) at −20°C
until stained. Hematoxylin and eosin staining were used for the analysis of mean myofiber
cross-sectional area and central nucleation, a hallmark of muscle degeneration/regeneration
cycles accordingly to the manufacturer’s protocol (Vector Laboratories, H3502). The ratio
of myofibers with centrally located nuclei to the total myofibers in the field was counted.
For immunostainings, sections were blocked with 5% BSA-PBS and incubated with the
primary antibody. Negative controls were performed by omitting the primary antibody.
Primary antibodies used in this study are laminin (Ab 11575, Abcam), Bax (#14796; Cell
Signaling Technology), cleaved caspase 3 (#9664), and RIPK3 (#95702). The primary
antibody was incubated in humid chambers at 37°C for 1h, the slides were rinsed in PBS
and

incubated

in

goat

anti-rabbit

(Alexa

(1:1000; Invitrogen) for 1 h.
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Fluor

488)

secondary

antibody

After a rinse in PBS, the slides were cover slipped with Vectorshield anti-fade mounting
medium with DAPI. Images were obtained using an inverted microscope (IX70; Olympus,
Tokyo, Japan) equipped with a DFC7000T camera (Leica Microsystems, Wetzlar,
Germany).

v.

TUNEL staining
Frozen muscle sections were deparaffinized, rehydrated, fixed with 4% paraformaldehyde,
and permeabilized using 0.1% Triton X-100 and 0.1% sodium citrate buffer. The
permeabilized sections were incubated for 1 hour in TUNEL (terminal deoxynucleotidyl
transferase dUTP nick end-labeling) reaction mixture from an in-situ cell death detection
kit (Roche, Indianapolis IN, USA), washed, and incubated with Vector shield anti-fade
mounting medium with DAPI (Vector Laboratories, H-1200). The protocol was followed
as described in Sigma Aldrich in-situ cell death detection kit.

vi.

Evans blue dye (EBD) assay
Evans Blue staining is an azo dye which detects the presence of serum albumin in cell or
tissue. Blood proteins such as serum albumin leak into the damaged tissues making the dye
detect those tissue stains red under fluorescence. To confirm the damaged muscle fibers
both wildtype and lipin1 deficient muscle fibers were injected with Evans Blue Dye
solution(10 mg/ml stock in sterile saline, 0.1 ml/10 g body weight) (intraperitoneal) and euthanized 24 hours later. The skeletal muscles were dissected and snapfrozen isopentane cooled optimal cutting temperature (OCT) embedding media (TissueTek, Sakura-Americas, Torrance CA, USA).
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Frozen muscle OCT blocks were cryo-sectioned at 5-7 µm thickness and stained with
laminin antibody before analyzed by fluorescence microscopy. The EBD stained damaged
muscle fibers are observed in red fluorescence as shown below in the Fig4.

Figure 4: A new procedure to detect the membrane damage especially
in the Lipin1Myf5cKO mice. (Fantin, A. et al., 2018).

Statistical analysis: All the graphs and data discussed are provided as the mean ± SE number
(n) of independent experiments. Statistical significance was calculated using a two‐tailed
Student's t-test. Force frequency was measured by the Boltzmann equation and paired t-test
using OriginPro 2019 or 2020 (OriginLab Corp., Northampton, MA).
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III.

DATA AND RESULTS

1. Lipin1 deficient skeletal muscle indicates a loss of muscle function.
To check the muscle function in the lipin1 deficient mice, our lab collaborated with
Dr. Andrew Voss’s lab to analyze the contractile force in both WT and
Lipin1Myf5cKO muscle fibers. His lab primarily worked on measuring the in vivo isometric
force to the planar flexor (including medial and lateral gastrocnemius). They calculated
the average WT and Lipin1Myf5cKO with the response to a single twitch (action potential)
and maximum tetanic force (measured for 0-100 Hz). They observed lower masses in
Lipin1Myf5cKO planar flexor muscles as a sign of muscle degradation. When the average
twitch and 100Hz frequency was measured in WT and Lipin1Myf5cKO were significantly
lowered in Lipin1Myf5cKO as compared to WT mice. A group of 13 wild type (WT) and
7 lipin1 deficient knockout (Lipin1Myf5cKO) mice were used for the experiment. As a result
of muscle degeneration, a marked reduction of total muscle contractile force was observed
in Lipin1Myf5cKO muscle fiber.
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2. Lipin1 deficiency induces the degeneration of muscle fiber.

In order to understand what causes the physiological defects in lipin1 deficient muscle. We
assessed the muscle morphology in Lipin1Myf5cKO muscles by performing Hematoxylin and
Eosin (H&E) histology (Figure 5A) to examine the degeneration of Lipin1Myf5cKO muscle
fibers. We observed degenerated myofibers in Lipin1Myf5cKO muscles, displayed
characteristics such as pale muscle fibers with cytoplasmic disruptions, regional hyper
contraction, cellular infiltration and my phagocytosis (white arrows, figure 5A).
This

staining

also

depicted

central

nucleation

muscle

fibers

in

Lipin1Myf5cKO muscle (white stars, Figure 5A). Quantitative analysis of the H&E stained
muscle showed that 37.46% of the Lipin1Myf5cKO but no WT gastrocnemius fibers had
central nuclei (Figure 5B, p = 1.0x10-4, n=5 mice/group), indicating an increase in skeletal
muscular degeneration in Lipin1Myf5cKO. Finally, figure 5C shows the fiber size distribution.
The shift in the bar graph is likely to explain the increase in the regeneration of myofibers
in the following result.
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Figure 5: Enhanced muscle degeneration is observed in Lipin1MyfcKO
H&E staining is performed on the gastrocnemius muscles of WT and lipin1Myf5cKO.
Figure 5A) shows the myofiber necrosis marked with arrows and asterisks in
lipin1Myf5cKO and WT doesn’t show any such attributes.
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Figure 5B) is the quantification for central nucleation present in both where n=5
mice/group. And finally, figure 5C) depicts the muscle fiber size of the gastrocnemius
muscle fibers. The wildtype (WT) is shown in black and the Lipin1Myf5cKO (KO) is shown
in red. Scale bar = 100 µm. ***p < 0.005
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3. Lipin1 deficiency leads to regeneration in Lipin1Myf5cKO muscle fibers.
Regeneration in skeletal muscle is a sign of injury occurring in lipin1 deficient skeletal
muscle. Degeneration and regeneration are a continuous process when the muscle in
undergoing injury or damaged conditions. To examine whether lipin1 deficient leads to
regeneration in skeletal muscle. We performed immunostaining for embryonic myosin
heavy chain (EMyHC, green), laminin (red), and nuclei (blue) (Figure 6A) staining on
WT and Lipin1Myf5cKO muscle sections. WT muscle fibers don’t show any kind of
green areas (EMyHC positive fibers) whereas Lipin1Myf5cKO muscle fibers show about
2.16% of expressed embryonic myosin which is consistent with the increased fiber
regeneration in Lipin1Myf5cKO muscle in the previous result section. Figure 6B shows
the quantification analysis of expressed embryonic myosin in WT and
Lipin1Myf5cKO muscle fibers (p = 5.45x10-6, n=7 mice/group).
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Figure 6: Enhanced regeneration in Lipin1Myf5cKO muscle fibers.

Immunostaining

for

Embryonic

myosin

(EMyHC)

in

WT

and Lipin1Myf5cKO

gastrocnemius muscle fibers. Figure 6A) depicts the fibers stained with green (EMyHC
positive fibers) and figure 6B) shows the number of EMyHC-stained fibers vs total fiber
number in the muscles. (n=7 mice/group). Scale bar = 100 𝜇m. ***p>0.005.
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4.

Lipin1 deficiency drives intrinsic apoptosis in Lipin1Myf5cKO muscle fibers.

To determine whether muscle degeneration in Lipin1Myf5cKO mice was due to the induction
of apoptotic or necrotic way of death, we first evaluated the protein expression of western
blots and supported those results with TUNEL-staining data. As shown in 7A and 7B,
western blotting was performed to analyze pro-apoptotic protein markers like Bax and Bak
which shows a considerable increase (205% and 330% with p = 0.02 respectively, n=3
mice/group) in gastrocnemius in Lipin1Myf5cKO muscle when compared to WT muscle. We
also checked the executioner apoptotic protein marker i.e. cleaved caspase 9. There was a
significant increase (231%, p = 0.007) of cleaved caspase 9 in Lipin1Myf5cKO muscle
compared with WT controls. The expression of the anti-apoptotic protein such as Bcl-2 was
also observed and compared to WT controls. The expression of the Bcl-2 was increased not
significantly different in Lipin1Myf5cKO muscle samples as compared to WT muscle samples
(p=0.07), indicating a protective response that may not be a direct consequence of lipin1
deficiency. Consequently, we detected apoptosis through DNA fragmentation by
performing TUNEL staining in the muscle sections. We detected no TUNEL positive in
WT muscle fibers but Lipin1Myf5cKO muscle sections showed positive to TUNEL staining
(figure 7C). In figure 7D, we quantitatively measured apoptotic nuclei revealed that
frequently of TUNEL-positive myonuclei increased to 1.41% in Lipin1Myf5cKO mice
(p=0.0003, n=3 mice/group). Moreover, we noticed that apoptosis was present both in
interstitial cells and myofibers in lipin1 deficient mice.
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Figure 7:Western blot analysis of apoptosis-related proteins and TUNEL assay in
gastrocnemius from WT and Lipin1Myf5cKO.
Figure 7A), Western blot assays of pro-apoptotic (Bax and Bak), anti-apoptotic marker
(Bcl-2), and apoptotic executioner marker (Cleaved Caspase 9) in gastrocnemius of WT
and Lipin1Myf5cKO mice. We used GAPDH as the loading control and confirmed the
expression of Lipin1 in the WT and Lipin1Myf5cKO muscle samples. Figure 7B) explains
the densitometry of western blots performed on the apoptosis markers which is
presented as mean ± SD from three individual experiments.
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Figure 7C) is the illustration of the immunofluorescence assessment of TUNEL staining
in the gastrocnemius of WT and Lipin1Myf5cKO mice. Those muscle sections were also
simultaneously stained with Laminin (green) and DAPI (blue) for the muscle
membrane and the nuclei. Finally, figure D) shows the quantification of TUNEL
positive

cells

(n=3

mice/group).

***p<0.005, Lipin1Myf5cKO versus WT measured by t-test.
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*p < 0.05;

**p<0.01,

5. Lipin1 deficiency induces muscle necroptosis in skeletal muscles.
We also examined the other type of cell death i.e. necrosis in skeletal muscles. We
aimed to study if the major contributor to cell death is through necroptosis
(programmed necrosis)? Also, if this kind of cell death can occur in the lipin1
deficient skeletal muscle. To evaluate this process of necroptosis, we performed
western blotting for proteins belonging to the necroptosis machinery i.e. RIPK1,
MLKL, and RIPK3. The enhanced expression of these proteins shows strong
evidence of necroptosis in lipin1 deficient skeletal muscles. We performed these
experiments on the gastrocnemius muscle tissue of the WT and Lipin1Myf5cKO mice.
These necroptosis proteins MLKL, RIPK1 and RIPK3 show a significant increase by
130% (p=0.047), 724% (p=0.018) and 496% (p=0.018) respectively when compared
to the WT muscle samples. These experiments were repeated to increase the
significance of the data produced (Figure 8A & 8B) (Considered n=3 mice/group).
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Figure 8:Western blot analysis was performed to understand the necroptosis markers in
gastrocnemius muscle of WT and Lipin1Myf5cKO
The above figure 8A) shows the western blot data of necroptosis markers i.e. RIPK3,
MLKL, and RIPK1 in WT and Lipin1Myf5cKO muscle samples. Figure 8B) depicts the
quantification analysis of this western blot. (n= 3 mice/group) (*p > 0.05)
The WT group was shown in Black and Lipin1Myf5cKO (KO) was shown in red.
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6. Plasma membrane breakdown in Lipin1MyfcKO muscle.
The loss of plasma membrane integrity is the depicts the presence of muscle
degeneration in the lipin1 deficient skeletal muscle. To identify these damaged
skeletal muscle fibers, we stained them with the membrane-impermeable marker
IgG. As shown in Figure 9A and 9B, gastrocnemius muscles from Lipin1Myf5cKO mice
demonstrated a 3.65% of total muscle fibers were IgG-positive compared to zero
in WT muscle (p = 7.7x10-8, n=6 mice/group), suggesting the loss of membrane
integrity.
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Figure 9: Membrane disruption was detected using an IgG staining method
in gastrocnemius sections of Lipin1Myf5cKO mice
The myofiber damage in Lipin1Myf5cKO mice was detected by IgG staining.
Figure 9A) gastrocnemius muscle sections from WT and Lipin1Myf5cKO mice were
immunostained with goat anti-mouse IgG to detect permeable/ damage fibers.
9B) Quantification (in %) of IgG- positive fibers (n=6 mice/group).
Scale bar = 200 𝜇m. ***p>0.005.
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7. To observe plasma membrane damage in Lipin1MyfcKO muscle by Evans blue
dye (EBD) staining.
The loss of plasma membrane integrity is a hallmark of necrotic cell death. To
identify these damaged skeletal muscle fibers, we performed Evans blue dye staining
in WT and Lipin1Myf5cKO muscle fibers. To confirm that these muscle fibers were
indeed damaged, we injected EBD into the Lipin1Myf5cKO and WT mice. As shown
in Figure 10A and 10B, 3.62% of EBD-positive fibers were detected
in gastrocnemius of Lipin1Myf5cKO mice, but not in WT mice (p = 5.42x10-7, n=5
mice /group).
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Figure 10: Evans blue dye (EBD) staining performed in gastrocnemius muscle
of Lipin1Myf5cKO mice
The membrane damage can also be detected in EBD stained WT and Lipin1Myf5cKO
muscle samples. Figure 10A) shows the representative images of EBD positive staining
in both wildtype muscle fibers (WT) and lipin1 deficient skeletal muscle fibers
(Lipin1Myf5cKO). Figure 10B) explains the quantification percentage of EBD-positive
necrotic fiber in Lipin1Myf5cKO mice (n=5 mice/group).
Scale bar = 200 𝜇m. ***p>0.005.
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8. To understand reduced muscle function as a result of myofiber's death and
disrupted muscle membrane.

To determine whether loss of membrane integrity could be induced in
necroptotic or apoptotic myofibers, we examined the co-localization of RIPK3 and
cleaved caspase-3 (ccp-3) with damaged EBD positive myofibers by using a common
immunoblotting technique (Figure 11). We found an intense colocalization between
EBD-positive staining with RIPK3 (Figure 11A), cleaved caspase-3 (Figure 11B) and
Bax (Figure 11C) in muscles from Lipin1Myf5cKO mice. Approximately, 80.94% of
RIPK3-positive muscle fibers and 81% of Cleaved Caspase-3-positive myofibers wereEBD positive (Figure 11D, n=4 mice/group). Interestingly, among the Bax-positive
myofibers, 95.4% myofibers were EBD-positive suggesting that membrane damage may
lead to the initiation of apoptosis. These staining data showed a strong association
between the loss of membrane integrity and necrotic/apoptotic cell death and supported
the implication that membrane disruption may lead to necroptotic/apoptotic myofibers.
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Figure 11:Colocalization of Evans blue dye staining with the RIPK3 (necroptosis marker),
BAX (Pro-apoptotic marker) and Cleaved-Caspase3(executioner apoptotic marker) in
gastrocnemius muscle fibers of the Lipin1Myf5cKO mice
Gastrocnemius muscles from WT and Lipin1Myf5cKO mice. These muscles were collected
from mice one-day post-injection of EBD, and muscle sections of the same were
immunostained with either primary antibodies against 11 A) RIPK3, 11 B) cleaved
caspase3(Ccp-3) or 11 C) Bax. 11 D) Comparison of percentages that are co-localized of
EBD with RIPK3, cleaved caspase 3, or Bax in WT and Lipin1Myf5cKO muscles, these were
examined and quantified (n=4 mice/group). Scale bar = 100 µm.
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IV.

DISCUSSION

Our data in this study showed that deficiency in lipin1 induces caspase-dependent
intrinsic apoptosis and also induce RIPK3-dependent necroptosis in skeletal muscles. The
present study showed that lipin1 deficiency can also lead to impaired membrane integrity
and reduced contractile force. The underlying cell death signaling events are enhanced
by lipin1 deficiency in skeletal muscles. Disrupted membrane integrity and cell death can
cause muscle degenerative diseases such as rhabdomyolysis, muscle dystrophy and
various other myopathies. This understanding about cell death events can help us develop
new treatment methods for these muscle disorders. The muscle degeneration and
regeneration were consequential in Lipin1Myf5cKO muscle samples having 37% of its fibers
to be centrally nucleated and 2% were expressing positive to embryonic myosin heavy
chain staining. Any healthy muscle fiber contains nucleation around the periphery of the
muscle fiber, but due to damage or injury muscle nuclear arrangement starts deforming.
This event causes the disposition of the nuclei in muscle fiber. This suggest that
Lipin1Myf5cKO muscle undergoes a recurrent cycle of degeneration and regeneration. This
particular pathology was also shown in a H&E staining of Lipin1Myf5cKO muscle samples
by Jama A. et al 2018 leading to muscle degeneration.
Our studies provide the first evidence that apoptotic and necroptotic cell death co-exists
in lipin1 deficient skeletal muscle acquired from Lipin1Myf5cKO mice. In respect to skeletal
muscles, there are three major cell death pathways: apoptosis, autophagic cell death, and
necrosis.
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(Zhang et al, 2014; Abdullah A. et al, 2018) proved that lipin1 deficiency in mice is
associated with a blockade in autophagic flux, a deregulated mitophagy, and a marked
accumulation of abnormal mitochondria and autophagic vacuoles in skeletal muscles. In
this present study, we observed that the elevations of TUNEL-positive nuclei and
apoptotic DNA fragmentation in lipin1 deficient muscles.
We observed enhanced intrinsic apoptosis by performing western blot to test proapoptotic markers BAX and BAK, and activation of the cleaved caspase 9 in WT and
lipin1 deficient muscle samples. Our data also indicated that there is upregulation of
necroptosis expression of RIPK1, MLKL, and more importantly RIPK in lipin1 deficient
skeletal muscles. This demonstrates that lipin1 deficiency does induce necroptosis
activation in skeletal muscles. (George G. Schweitzer et al, 2019). On the contrary,
apoptosis and necrosis can coexist in the degenerating/ regenerating muscles, including
those of patients with neuromuscular disorders, such as inflammatory myopathies,
dystrophies, metabolic and mitochondrial myopathies and drug-induced myopathies
(Sciorati C, 2016). Our data have also showed loss of membrane integrity is strongly
associated with necroptosis and apoptosis. It has been proposed that the initial events in
the muscle cell necrosis in a variety of pathological conditions including Duchenne
Muscular Dystrophy (DMD) are the focal breakdown of the plasmalemma (Nadra K et
al, 2008) (Mokri B, 1998). Membrane rupture allows the influx of calcium and leads to
necrotic muscle fiber death. Our data showed that approximately 81% of RIPK3
myofibers were EBD-positive, suggesting the disruption of membrane integrity occurs
relatively early and may lead to necroptosis. Lipin1 is an
Mg2+-dependent

phosphatide

phosphatase

(PAP1)

enzyme

catalyzing

the

dephosphorization of phosphatidic acid, yielding diacylglycerol which are lipid
precursors used for the synthesis for the major membrane phospholipids
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phosphatidylethanolamine and phosphatidylcholine. phosphatidylethanolamine and
phosphatidylcholine are the most important lipoproteins for maintaining the membrane
structure, fluidity, and stability (Li Z et al, 2006). These proteins tend to affect membrane
protein trafficking (Shuler MH et al, 2016) (Testerink N. 2008). Lipin1 deficiency may
affect membrane integrity by altering membrane phospholipid contents and affecting
membrane protein expression. Moreover, it is generally accepted that loss of membrane
integrity occurs late in apoptosis (Nelson J et al, 2011) (Rogers C et al, 2017).
Interestingly, we observed pro-apoptotic marker Bax-positive muscle fibers highly
colocalized with EBD- positive muscle fibers. It suggests that loss of membrane integrity
may contribute to the early stages of apoptosis. This is consistent with the previous study
that increased membrane permeability which may lead to the induction of calcium influx
and eventually trigger apoptosis (Matsuda R et al, 1995). Therefore, plasma membrane
changes during apoptosis and programmed necrosis are more complicated than
previously expected. We understand that lipin1-deficient muscles, depending on the
extent of cell membrane damage, the cellular response may be adaptive and where
possible, homeostasis is restored. Cell death may undergo necrosis or apoptosis, which
depends on the severity of muscle damage. As a consequence of muscle degeneration, a
marked reduction of total muscle force was observed. When isometric forces were
corrected for the muscle mass (the specific force, N/g), there was still a significant
difference in the force between lipin1 deficient and control mice suggesting that a defect
in Lipin1Myf5cKO muscle in addition to the atrophy conditions.
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Certainly, previous studies have reported that sarcolemma disruption has been implicated
that reduction of muscle force after muscle injury is a common event to occur. Lovering
and De Deyne identified a complementary correlation between maximal tetanic tension
and EBD-positive muscle fibers suggesting that membrane integrity plays a critical role
in the maintenance of muscle contractile force (Lovering RM and De deyne PG, 2004).
Enhanced apoptosis and necroptosis could change contractile properties and leads to
reduced contractile force production.
We examined the limitation of the current study and identify areas for future research.
Despite revealing that lipin1 plays an important role in protecting against myofiber
degeneration and maintain membrane integrity. Inadequate membrane repair has been
implicated to participate in the pathogenesis of muscular dystrophies and
cardiomyopathies. (Han R et al, 2007), (Lammerding J et al, 2007). Our future direction
would be to examine whether lipin1 deficiency leads to defective membrane repair.
Furthermore, we have determined lipin1 deficiency induces coexisted myocyte apoptosis
and necrosis. This enable further investigation into whether myocyte apoptosis and
necrosis are two separate processes or a continuum of events and the conditions the cells
choose between different types of cellular deaths or survival.
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In brief, we found that loss of plasma membrane integrity due to lipin1 deficiency in
skeletal muscle fibers may play a primary role in the death of the muscle fibers and the
course of related muscle disorders. We demonstrate that muscle loss from atrophy and
degeneration induced by lipin1 deficiency results in impaired force production. We
propose that lipin1-mediated muscle degeneration and higher muscle membrane
vulnerability are some of the potential mechanisms that lead to muscle weakness. Our
data provided a novel point for an understanding of the mechanism that regulates muscle
cell death, which could be utilized for the effective treatment of related muscle diseases.
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